Cancer vaccine

Prognostic factors related to dendritic cell vaccines on patients with advanced non-small cell lung cancers: a multicenter analysis
Hidenori Takahashi, Shigetaka Shimodaira, Masahiro Ogasawara, Masanori Kobayashi, Hirofumi Abe, Kazuhiro Nagai, Sunichi Tsujitani, Masato Okamoto, Yuji Morita, Yoshikazu Yonemitsu

Journal for ImmunoTherapy of Cancer Dec 2015, 3 (Suppl 2) P451; DOI: 10.1186/2051-1426-3-S2-P451
Peptide libraries for the comprehensive coverage of the tumor mutanome for immune monitoring and immuno therapy
Paul von Hoegen, Tobias Knaute, Holger Wenschuh, Ulf Reimer

Journal for ImmunoTherapy of Cancer Dec 2015, 3 (Suppl 2) P265; DOI: 10.1186/2051-1426-3-S2-P265
Plasma biomarker analysis of ovarian cancer patients undergoing immunotherapy with therapeutic cancer vaccine DPX-Survivac
Mohan Karkada, Devanand Pinto, Eve Teh, Kenneth Chisholm, Tara Quinton, Neil Berinstein, Marc Mansour

Journal for ImmunoTherapy of Cancer Dec 2015, 3 (Suppl 2) P95; DOI: 10.1186/2051-1426-3-S2-P95
Programming the lymph node microenvironment to enhance anti-tumor T cell immunity in neuroblastoma
Joshua M Gammon, Christopher M Jewell

Journal for ImmunoTherapy of Cancer Dec 2015, 3 (Suppl 2) P434; DOI: 10.1186/2051-1426-3-S2-P434
L-tyrosine is a promising cancer vaccine adjuvant
Hiep Khong, Meenu Sharma, Zhimin Dai, Manisha Singh, Yared Hailemichael, Willem Overwijk

Journal for ImmunoTherapy of Cancer Dec 2015, 3 (Suppl 2) P440; DOI: 10.1186/2051-1426-3-S2-P440
Defining the effects of age and gender on clinical immune response to cancer vaccination
Adriana Ramirez, Nolan Wages, Mark E Smolkin, Craig L Slingluff

Journal for ImmunoTherapy of Cancer Dec 2014, 2 (Suppl 3) P59; DOI: 10.1186/2051-1426-2-S3-P59
Comparison of proteomic and genomic analyses of vaccine cell lines shows men receiving prostate gvax immunotherapy develop increased humoral responses to common cell line proteins relative to mutated proteins
Tyler Hulett, Sachin Puri, Brendan Curti, Walter J Urba, Bernard A Fox

Journal for ImmunoTherapy of Cancer Dec 2014, 2 (Suppl 3) P49; DOI: 10.1186/2051-1426-2-S3-P49
Impact of age on antigen-specific T lymphocyte response in patients treated with PSA-TRICOM
Harpreet Singh, Ravi Madan, Jennifer Marte, Geraldine O'Sullivan-Coyne, Seth Steinberg, Christopher Heery, Jeffrey Schlom, James Gulley

Journal for ImmunoTherapy of Cancer Dec 2014, 2 (Suppl 3) P155; DOI: 10.1186/2051-1426-2-S3-P155
CD4 T cells transduced with CD80 and 4-1BBL mRNA induce long-term CD8 T cell responses resulting in potent antitumor effects
Hyun-Il Cho, Hye-Mi Park, Hyun-Jung Shon, Tai-Gyu Kim

Journal for ImmunoTherapy of Cancer Dec 2014, 2 (Suppl 3) P264; DOI: 10.1186/2051-1426-2-S3-P264
Persistent immunity after therapeutic vaccination targeting HER2/neu correlated with post-vaccination magnitude of interferon gamma Elispot responses
John B Liao, Jessica L Reichow, Doreen M Higgins, Jennifer S Childs, Lupe G Salazar, Mary L Disis

Journal for ImmunoTherapy of Cancer Dec 2014, 2 (Suppl 3) P53; DOI: 10.1186/2051-1426-2-S3-P53

Main menu

Cancer vaccine

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

Cancer vaccine

Pages